Literature DB >> 2436766

Immunocytochemical demonstration of estrogen receptors by monoclonal antibodies in human breast cancer: correlation with estrogen receptor assay by dextran-coated charcoal method.

E Marchetti, P Querzoli, B Moncharmont, I Parikh, A Bagni, A Marzola, G Fabris, I Nenci.   

Abstract

Immunocytochemical demonstration of estrogen receptors in 115 human breast cancer specimens was performed using mouse monoclonal antibodies against estrogen receptor and avidin-biotin as the displaying system. The antibody indicated a highly heterogeneous endowment of neoplastic cells with estrogen receptor at both nuclear and cytoplasmic levels. The percentage of labeled cells within each tumor specimen was recorded to compare this immunocytochemical assay with the biochemical assay of estrogen receptors by the dextran-coated charcoal method. A significant correlation was observed between these two assays. The present results show that estrogen receptors can be confidently demonstrated at the single cell level, thus providing additional information to quantitative biochemical assays. Their prognostic and therapeutic predictive powers may be usefully integrated, particularly in view of the heterogeneous distribution of receptors among cancer cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2436766

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Assessment of oestrogen receptor content of breast carcinoma by immunohistochemical techniques on fixed and frozen tissue and by biochemical ligand binding assay.

Authors:  D A Paterson; C P Reid; T J Anderson; R A Hawkins
Journal:  J Clin Pathol       Date:  1990-01       Impact factor: 3.411

2.  Immunocytochemical staining of progesterone receptor in paraffin sections of human breast cancers.

Authors:  M Perrot-Applanat; M T Groyer-Picard; M T Vu Hai; C Pallud; F Spyratos; E Milgrom
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

3.  Sequential determination of immunocytochemical estrogen receptor and nuclear DNA content in fine needle biopsies from breast carcinoma.

Authors:  C B Pestana; N Donozo; A J Pinto; P C de Almeida; G M Machado-Santelli
Journal:  Breast Cancer Res Treat       Date:  1991-09       Impact factor: 4.872

4.  Expression of epidermal growth factor receptor (proto-oncogene c-erbB-1) and estrogen receptor in human breast carcinoma. An immunocytochemical study of 70 cases.

Authors:  C Garcìa Castro; M Ravina; V Castro; E C Salido
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

5.  Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation.

Authors: 
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

6.  Interaction of vault particles with estrogen receptor in the MCF-7 breast cancer cell.

Authors:  C Abbondanza; V Rossi; A Roscigno; L Gallo; A Belsito; G Piluso; N Medici; V Nigro; A M Molinari; B Moncharmont; G A Puca
Journal:  J Cell Biol       Date:  1998-06-15       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.